A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension
Clinical trial NCT05203510 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05203510
- Sponsor
- United Therapeutics
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-20
- Primary completion
- 2026-04-30
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.